Lantern Pharma Current Assets

Lantern Pharma (LTRN) currently reports a current assets of $7.1M as of March 2026. That compares with $21M in the prior-year period — down 66.1% year over year. Use the charts on this page to explore Lantern Pharma's current assets history and peer comparisons.

Lantern Pharma's current assets decreased from $21M to $7.1M — a 66.1% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lantern Pharma reported $7.1M in current assets as of March 2026. That compares with $21M in the prior-year period — down 66.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $7.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lantern Pharma, and consider following LTRN for alerts when major investors trade the stock.

Lantern Pharma is classified in the Healthcare sector. On current assets, it currently shows $7.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LTRN with unrelated industries.